Mitesh

MHRA Class 4 Medicines Defect Information: Rosuvastatin 20mg, 40mg tablets (Sandoz Ltd) Drug alert number: EL (24)A/45 Date issued: 01 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Rosuvastatin 20mg, 40mg tablets (Sandoz Ltd) Company name: Sandoz Ltd Product name: Rosuvastatin 20mg tablets, PL [...]

The post MHRA Class 4 Medicines Defect Information: Rosuvastatin 20mg, 40mg tablets (Sandoz Ltd) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Cefalexin 500mg tablets are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP072 Cefalexin 500mg tablets expires at 23.59pm on Friday 27 September 2024. After this date, any prescriptions for Cefalexin 500mg tablets must be [...]

The post Expiry of SSP072 Cefalexin 500mg tablets appeared first on Community Pharmacy England.

Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 15 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 October 2024. This takes the total [...]

The post 15 products added to the Discount Not Deducted (DND) list from October 2024 appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 2 September 2024) has been published and includes articles on: Valproate use in men: as a precaution, men and their partners should use effective contraception Letters and medicine recalls sent to healthcare professionals in August 2024. To see the latest [...]

The post MHRA Drug Safety Update: September 2024 appeared first on Community Pharmacy England.

As announced in the NHS Primary Care bulletin (published 19 September 2024), from 1 January 2025, GP practices will be able to order the sub dermal contraceptive implant (Nexplanon® 68mg implant) directly from their suppliers and claim back the cost.  This will mean that patients do not have to go to the pharmacy to pick [...]

The post Changes to supply route for sub dermal contraceptive implants (Nexplanon®) appeared first on Community Pharmacy England.